Quotient to expand Alnwick
Quotient Sciences is to invest £6.3 million to expand drug substance manufacturing at the site in Alnwick, UK, which it acquired along with Arcinova in February. This will also create 80 new jobs over the next three years and boost its capacity to develop complex medicines tenfold.
The company plans to repurpose 1,500 m2 of space to incorporate more equipment and technologies. This, it said, will feature “the latest advances in digital control and data capture”, to “ensure robust transfer from laboratory to multi-kilo scale production”. There will also be processing equipment with new developments in modular continuous technology.